Similar articles

• Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.

  Taha TE, Kumwenda J, Cole SR, Hoover DR, Kafulafula G, Fowler MG, Thigpen MC, Li Q, Kumwenda NI, Mofenson L. Taha TE, et al. J Infect Dis. 2009 Nov 15;200(10):1490-7. doi: 10.1086/644598. J Infect Dis. 2009. PMID: 19832114 Clinical Trial.
• Preventing mother-to-infant transmission of HIV in the developing world.

  Laurence J. Laurence J. AIDS Read. 1999 Oct;9(7):448-9, 496. AIDS Read. 1999. PMID: 12737134 No abstract available.
• Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.

  Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F. Tonwe-Gold B, et al. PLoS Med. 2007 Aug;4(8):e257. doi: 10.1371/journal.pmed.0040257. PLoS Med. 2007. PMID: 17713983 Free PMC article.
• Preventing mother-to-child transmission of HIV: successes and challenges.

  McIntyre J. McIntyre J. BJOG. 2005 Sep;112(9):1196-203. doi: 10.1111/j.1471-0528.2005.00716.x. BJOG. 2005. PMID: 16101596 Review.
• The impact of gender and pregnancy on antiretroviral therapy for HIV: pharmacokinetic and disease-related differences.

  Scarsi KK, Postelnick MJ. Scarsi KK, et al. J Gend Specif Med. 2003;6(1):7-16. J Gend Specif Med. 2003. PMID: 12661172 Review. No abstract available.